well Special Team of JST Health Care equipped with High-end technology to take care of aged Patients. Specially trained team to support aged patients post surgery and aged patients affected by one or more form of cardiovascular disease.
In India, approximately 5 million adults over the age 65 are affected by one or more forms of cardiovascular disease and it remains the leading cause of morbidity and mortality in this population. Among older adults, therapeutic goals for cardiovascular diseases (CVD) are often confounded by comorbid diseases and/or conditions that dominate their overall sense of health and well-being. Thus, even while CVD is usually considered a principal concern, management is often complicated by concomitant medical challenges. Whereas, evidence-based care is often premised primarily on goals to increase longevity, the circumstances associated with multimorbidities [e.g., cancer, chronic obstructive pulmonary disease (COPD), Parkinson disease, dementia, and chronic kidney disease] may undercut the perceived value of prolonging life. Thus, in addition to mortality benefit, other effects of cardiovascular (CV) therapy and/or management processes are important as well.
In addition to life prolongation, goals to preserve functional capacity (including cognitive and physical function), maintain independence and quality of life, reduce hospitalization, reduce pain, and moderate personal costs may all be just as or even more important from the patient’s perspective. Therefore, decisions regarding cardiovascular treatment in older adults need to be individualized to each patient’s overall health context, comorbid illness, functional status, life expectancy and personal preferences.
Process of care is also particularly relevant to quality of care for older adults. Many older adults are burdened by sensory and/or cognitive limitations that limit their ability to hear, see, and/or understand their medical circumstances. Extra effort should be made to convey information in a manner that is accessible to each patient
Age-related changes impact the efficacy and complexity of providing standard CV therapies as well. Changes in pharmacokinetics, pharmacodynamics, metabolism, frailty and adverse events related to medications including increased prevalence of side effects (e.g., fatigue, changes in taste, dizziness, and depression) demand therapeutic approaches that are better attuned to each patient’s particular state and physiologic capacities
